CEHADO
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87233004 |
| Registration Number | 5404424 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Christopher M. Hanes |
| Attorney Name | Christopher M. Hanes |
| Attorney Docket Number | 81973135 |
| Law Office Assigned | M80 |
| Employee Name | RYDLAND, STEPHANIE DIA |
Timeline
| 2016-11-10 | Application Filed |
| 2017-12-05 | Published for Opposition |
| 2018-02-20 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-02-20 | Status: Live/Registered |
| 2018-02-20 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Entity Statement | partnership limited by shares |
| Address | 980 Great West Road Brentford, Middles GB TW89GS |
| Legal Entity Type | |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of dermatological diseases and conditions |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-11-14 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-11-16 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-01-26 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-01-27 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-01-27 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-01-27 | 6 GNRN O:Outgoing Correspondence |
| TEAS PETITION TO REVIVE RECEIVED | 2017-08-02 | 7 PROA I:Incoming Correspondence |
| PETITION TO REVIVE-GRANTED | 2017-08-02 | 8 PETG O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-08-02 | 9 TROA I:Incoming Correspondence |
| NOTICE OF REVIVAL - E-MAILED | 2017-08-02 | 10 NREV E:E-Mail |
| ASSIGNED TO LIE | 2017-08-23 | 11 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-08-25 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-08-25 | 13 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2017-09-07 | 14 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2017-09-07 | 15 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2017-09-07 | 16 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2017-10-18 | 17 ERFR I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2017-10-27 | 18 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2017-10-27 | 19 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-10-27 | 20 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-10-27 | 21 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-10-27 | 22 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-11-15 | 23 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-12-05 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-12-05 | 25 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2018-02-20 | 26 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-10-28 | 27 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-10-28 | 28 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-10-28 | 29 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-02-20 | 30 REM1 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CEHADO 87233004 5404424 Live/Registered |
Glaxo Group Limited 2016-11-10 |
 CEHADO 85872890 not registered Dead/Abandoned |
Glaxo Group Limited 2013-03-11 |
 CEHADO 79024307 3318502 Dead/Cancelled |
Glaxo Group Limited 2006-05-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 